SCHEMBL18624716

SCHEMBL18624716

C=C(C)NCC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25701106 0.80
Hydrochloric Acid SCHEMBL29088682 0.78
SCHEMBL22570009 0.78 CYP2D6 (0.44)
SCHEMBL14901030 0.76
SCHEMBL13831243 0.74 CYP2D6 (0.46)
SCHEMBL21884806 0.74
SCHEMBL22019223 0.74
SCHEMBL366427 0.74 CYP2D6 (0.52)
SCHEMBL25975594 0.74
SCHEMBL24529778 0.72 CYP2D6 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019243550-A1 THIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS CAUSED BY IGE UCB Biopharma SRL (BE) 2019-12-26 WO disclosed
EP-2890374-B1 COMPOSITIONS AND METHODS FOR DRUG-SENSITIZATION OR INHIBITION OF A CANCER CELL TEXAS A & M UNIV SYS (US) 2019-04-03 EP disclosed
US-9867807-B2 Compositions and methods for drug-sensitization or inhibition of a cancer cell THE TEXAS A&M UNIVERSITY SYSTEM (US) 2018-01-16 US disclosed
US-9867807-B2 Compositions and methods for drug-sensitization or inhibition of a cancer cell THE TEXAS A&M UNIVERSITY SYSTEM (US) 2018-01-16 US disclosed
US-9765087-B2 Benzimidazole derivatives ENANTA PHARMACEUTICALS, INC. (US) 2017-09-19 US disclosed
EP-2341140-B1 Enzymatic encoding methods for efficient synthesis of large libraries NUEVOLUTION AS (DK) 2017-07-19 EP disclosed
US-20170114046-A1 NOVEL BENZIMIDAZOLE DERIVATIVES ENANTA PHARM INC (US) 2017-04-27 US disclosed
US-20170071905-A1 COMPOSITIONS AND METHODS FOR DRUG-SENSITIZATION OR INHIBITION OF A CANCER CELL THE TEXAS A&M UNIVERSITY SYSTEM 2017-03-16 US disclosed
US-20170071905-A1 COMPOSITIONS AND METHODS FOR DRUG-SENSITIZATION OR INHIBITION OF A CANCER CELL THE TEXAS A&M UNIVERSITY SYSTEM 2017-03-16 US disclosed